Important Information
If you are interested in applying for this study, please:
- Read the study description and study information document.
- Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
- Complete the registration form below.
We will then contact you to check your suitability.
Study Information
New Zealand Clinical Research is trialling an experimental drug to observe the safety, tolerability and how the drug is broken down and eliminated from the body. If this study is successful, this experimental drug may potentially be used for the treatment of HIV type 1 (human immunodeficiency virus). HIV is a virus that attacks the immune system, the body’s defence, against diseases. Chronic infection of HIV can lead to an impaired immune system which leads to Acquired Immunodeficiency Syndrome (AIDS).
Typically, HIV-1 infection is treated with a combination of oral ARV (antiretroviral) drugs which delay disease progression. These drugs generally need to be taken every day and require strict adherence to be optimally effective. This drug is being tested as it is hoped that it can provide an alternative treatment, being administered on a less frequent basis.
This study (2023 FULL 15407) is being funded by Gilead Sciences, Inc and has been approved by the Health and Disability Ethics Committee.
This study will test an experimental drug, which is being developed as a potential antiviral treatment for HIV-1. The drug has been approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) in a different formulation than what is being investigated in this study. Thus, the drug used in this study is an investigational product because it has not been approved by the New Zealand MedSafe or other drug regulatory authorities.
Requirements
Healthy Males and Females
-
- Be aged 18+
- BMI (Body Mass Index) below 25 kg/m² or above 40 kg/m²
- Non-smokers, or have stopped more than 6 weeks ago
- Not currently taking any regular prescription medications for your health (e.g., anti-depressants)
What is Involved?
Study Visits: 15 night stay + 21 visits + 4 phone calls calls
Reimbursement: Up to $14,000 before tax